NASDAQ, ONCY - Oncolytics Biotech Inc
We focus on the discovery and development of oncolytic viruses for the treatment
of cancers that have not been successfully treated with conventional
therapeutics. Recent scientific advances in oncology, virology, and molecular
biology have created opportunities for new approaches to the treatment of
cancer. The product we are presently developing may represent a novel treatment
for Ras-mediated cancers which can be used as an alternative to existing
cytotoxic or cytostatic therapies or as an adjuvant therapy to conventional
chemotherapy, radiation therapy, or surgical resections. It could also
potentially be used to treat certain cellular proliferative disorders for which
no current therapy exists.
Our technologies are based primarily on discoveries in the Department of
Microbiology and Infectious Diseases at the University of Calgary in the 1990s.
Oncolytics Biotech Inc. ...
Read SEC Filing on NASDAQ.com »